San Francisco, CA, United States of America

Holger Wesche

This inventor holds 27 USPTO granted patents and 24 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Harpoon Therapeutics, Inc., Amgen Inc., Amgen Research (Munich) Gmbh. Active years: 2004-2026.

USPTO Granted Patents = 27 (Patent Applications = 24)

% Patents Active = 81.5

CIPO Patents = 1 (Patent Applications = 21)

EPO Patents = 6 (Patent Applications = 33)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 121(Granted Patents)

Location History:

South San Francisco, CA (US) (2020 - 2022)
San Francisco, CA (US) (2004 - 2024)

Company Filing History:

19 out of 25

Harpoon Therapeutics, Inc.

Amgen Research (Munich) Gmbh

patents

4. 1 out of 1,224

Takeda Pharmaceutical Company Limited

patents

5. 1 out of 10

Tcr2 Therapeutics Inc.

Washington University

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516128 - EPCAM BINDING PROTEINS AND METHODS OF USE (2026-01-06),

2. 12441796 - Antibody constructs for CDH19 and CD3 (2025-10-14),

3. 12415860 - Binding moiety for conditional activation of immunoglobulin molecules (2025-09-16),

4. 12371504 - Trispecific proteins and methods of use (2025-07-29),

5. 12195544 - EGFR binding proteins and methods of use (2025-01-14),

6. 12128102 - Constrained conditionally activated binding proteins (2024-10-29),

7. 12084518 - Trispecific binding proteins and methods of use (2024-09-10),

8. 11976125 - B cell maturation antigen binding proteins (2024-05-07),

9. 11807692 - DLL3 binding proteins and methods of use (2023-11-07),

10. 11607453 - Mesothelin binding proteins (2023-03-21),

11. 11535668 - Inducible monovalent antigen binding protein (2022-12-27),

12. 11498964 - Antibody constructs for CDH19 and CD3 (2022-11-15),

13. 11180563 - FLT3 binding proteins and methods of use (2021-11-23),

14. 11136403 - Trispecific proteins and methods of use (2021-10-05),

15. 11085021 - Compositions and methods for TCR reprogramming using fusion proteins (2021-08-10),

Title: Holger Wesche - Pioneering Inventor from San Francisco

Introduction: Holger Wesche is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Wesche holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the industry, Wesche has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized the way we approach complex challenges.

Collaborations: Throughout his career, Wesche has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Holger Wesche's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.